Jun Suzuki

Dr. Jun Suzuki is currently the Senior Advisor of Teijin Limited and was previously the Chairperson and Member of the Board at Teijin Limited. From 2014 to 2022, he was the President & CEO of the company. Since joining the company in 1983, he has played several leading roles in Teijin Group’s global operations in both material and healthcare/pharmaceutical businesses, placing “humanness” at the center of his work in the fast-changing era of digital technology.  

Dr. Suzuki serves as Vice Chairman of the Japan Association of Corporate Executives (Keizai Doyukai) and the Executive Member of the Policy Board of the Japan Business Federation (Keidanren). He represents Japanese business communities in high-level multilateral fora, and contributes to numerous business initiatives with key government, private sector, and civil society partners. In January 2023, he was appointed as a Member of APEC Business Advisory Council (ABAC) by Japan’s Prime Minister Kishida, and actively collaborates with other APEC economies to explore mutually beneficial steps to advance “digital health” in the APEC region.    

Dr. Suzuki holds a BSc and a MSc in Zoology from the University of Tokyo. He also received a PhD in Neuroscience from Osaka University.